The FDA breakthrough status and positive trial results for M...
The FDA breakthrough status and positive trial results for MM120 are seen as significant developments for Mind Medicine, leading to a surge in its stock price and an increased price target from Roth Capital Partners.
Mind Medicine Sends Psychedelic Stocks Higher After FDA Status for LSD Formulation
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment